[A follow-up on the endometrial status of patients in the postmenopause taking hormonal replacement treatment].
Dimiter B. Georgiev, Netsov
Abstract
Dimiter B. Georgiev, Netsov
Abstract
Endovaginal ultrasound could be a useful fool for follow-up of patients taking hormone replacement therapy. In the presented study a group of 140 postmenopausal women has been evaluated and in 10 patients the sonography disclosed endometrial thickness of more than 12 mm. Biopsy in the study group revealed three cases of endometrial hyperplasia and all they were in the patients with uterine lining thicker than 12 mm. In patients taking hormone replacement therapy endometrial thickness of more than 12 mm should be regarded as indication for D&C.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Endovaginal ultrasound could be a useful fool for follow-up of patients taking hormone replacement therapy. In the presented study a group of 140 postmenopausal women has been evaluated and in 10 patients the sonography disclosed endometrial thickness of more than 12 mm. Biopsy in the study group revealed three cases of endometrial hyperplasia and all they were in the patients with uterine lining thicker than 12 mm. In patients taking hormone replacement therapy endometrial thickness of more than 12 mm should be regarded as indication for D&C.
Key concepts: Medicine, Hormone replacement therapy (female-to-male), Endometrial hyperplasia, Endometrial biopsy, Gynecology, Endometrium, Postmenopausal women, Estrogen replacement therapy